Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SELUTION SLR™ 014 BTK: A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI)

NCT05055297 is registered in ClinicalTrials.gov with M.A. Med Alliance S.A. as lead sponsor.

NCT NCT05055297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05055297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SELUTION SLR™ 014 BTK: A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR™ 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI)
Lead sponsor
M.A. Med Alliance S.A.
Phase
Not applicable
Overall status
Recruiting
Start date
May 19, 2022
Completion date
July 30, 2032
Enrollment
376 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

chronic limb-threatening ischemia nos of native arteries of extremities, peripheral arterial disease